Search

everythinglearnresearchcommunity

for

Search:↓

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Different hair fiber development might explain why hair loss severity varies in patients with a specific genetic mutation, and treatments that thicken hair could help.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

There's no significant genetic link between male pattern baldness and COVID-19.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

The combination of laser and topical steroids is more effective for treating alopecia areata than topical steroids alone.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Early treatment helps stop hair loss in women of color.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Gray hair is caused by reduced melanin production or transfer issues, linked to aging and possibly health conditions, with treatments focusing on color camouflage.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.